Isodiol International Inc. Announces Minimum $5,000,000 and Maximum $10,000,000 Convertible Debenture Offering

November 7, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) is pleased to announce that it has entered into an engagement agreement with Haywood Securities Inc. (“Haywood”), to act as sole book runner and co-lead agent with Clarus Securities Inc. (together with Haywood, the “Co-Lead Agents”)…

Read More

Isodiol International Inc. Announces Appointment of Franco Columbu to Iso-Sport Management Team

October 29, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), is pleased to announce that actor, author, former champion bodybuilder and World’s Strongest Man competitor, Franco Columbu, has joined the management team at Iso-Sport. Mr. Columbu will focus on the business development of Iso-Sport and raise…

Read More
ISO SPORT - CBD performance products

ISO-SPORT™ Products Now Available Through Two UK-based Mixed Martial Arts Companies

October 16, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), is pleased to announce that its subsidiary, ISO-SPORT™, has reached deals with two United Kingdom-based mixed martial arts retailers to sell the CBD Performance Products. Acclaimed as being two of the U.K.’s top online sources of…

Read More

BSPG Laboratories Ltd., a Subsidiary of Isodiol International Inc., Launches API Sales and Marketing Program at CPhI 2018

October 5, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), is pleased to offer a reliable source of GMP-compliant cannabidiol (CBD), extracted from industrial hemp to pharmaceutical companies and research groups for human and animal use at CPhI 2018 in Madrid, Spain. BSPG Laboratories, a U.K.-based…

Read More

Isodiol International Inc. Applauds U.S. Drug Enforcement Agency ( DEA ) Rescheduling of Select Pharmaceuticals Made with Cannabidiol ( CBD )

September 28, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) applauds the Drug Enforcement Administration’s (DEA) decision in the long-anticipated rescheduling of CBD following the Federal Drug Administration’s (FDA) approval of GW Pharmaceutical’s FPP, Epidiolex, for the treatment of seizures associated with two forms of epilepsy.[1] The…

Read More
Isodiol Logo

Isodiol International Inc. Appoints Patrick Ogle as Chief Operating Officer and as a member of its Board of Directors; Appoints Dr. David Putrino, Ph.D., to Medical Advisory Board

September 14, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company”)  announces that its general counsel for M&A, Corporate and Securities, Patrick Ogle has been appointed as the Company’s Chief Operating Officer (“COO”) and as a member of its Board of Directors. Mr. Ogle is a seasoned general counsel…

Read More
Isodiol Logo

ISODIOL INTERNATIONAL INC. RELEASES AMENDED FINANCIALS

September 10, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), announces as a result of a review by the British Columbia Securities Commission, the Company is issuing the following press release to clarify our disclosure. The Company announces that it has filed revised Audited Annual Financial…

Read More
Isodiol Logo

ISODIOL INTERNATIONAL INC. PROVIDES UPDATE

August 31, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, announces that the amended filings of the Company’s annual financial statements for the fiscal year ended March 31, 2018, have been submitted to the BCSC. Upon approval from the…

Read More

ISODIOL INTERNATIONAL INC. APPOINTS MARVIN WASHINGTON TO ITS BOARD OF DIRECTORS

August 30, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, announces the appointment of Marvin Washington, VP of business development for Isodiol International Inc. and brand ambassador for ISO-Sport, to its Board of Directors. Mr. Washington is a retired…

Read More
CFO

Isodiol International Inc. Announces Appointment of New Chief Financial Officer

August 29, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company”), a global CBD innovator and leader specializing in hemp-based health and wellness products, announces that Mr. Eli Dusenbury, CPA, CA, has been appointed as the Company’s new Chief Financial Officer.  Mr. Dusenbury has over 8 years of public accounting…

Read More

Isodiol International Inc. Enters Hemp Beer and Related Functional Beverage Sector Through Its Subsidiary, IsoBev

August 20, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD leader and innovator is pleased to announce the progress of its months-long efforts to develop new hemp-based beers and functional beverages. In May 2018, IsoBev Inc. (“IsoBev”), a wholly owned subsidiary of Isodiol, acquired…

Read More